Peptides against hospital germs: the long road to market readiness

Nermina Malanovic is researching active substances against multi-resistant pathogens. Photo: University of Graz/Tzivanopoulos

Multiresistant germs are a threat to global health. At the University of Graz, Nermina Malanovic is researching peptides as a potential new weapon. Thanks to external funding, the preclinical phase for this alternative to conventional antibiotics has been able to start.

For decades, it was unthinkable that a simple infection could suddenly become life-threatening. But according to the World Health Organisation (WHO), this is one of the three greatest threats to public health. The reason: the increasing spread of multiresistant bacteria, which could cause around ten million deaths by 2050. Researchers around the world are therefore searching for new treatments against live threatening hospital germs.

One promising solution is peptides – tiny proteins that Nermina Malanovic is researching at the University of Graz. These small molecules can penetrate the outer wall of cells and break them open. Without this protective skin, bacteria cannot survive. This allows the organisms to be stopped before they cause any damage. Malanovic has already registered two patents for her research.

Preclinical

Thanks to her success, Nermina is often asked where these peptides can be obtained. Unfortunately, the answer is still nowhere. However, that could change soon. "A medical incubator has taken notice of my research," explains Malanovic. The company is financing the preclinical studies with a seven-figure sum – the first step in the development of drugs.

This also presents the researcher with new challenges. "You have to understand the mechanisms of action really well in order to plan the preclinical trials correctly," explains the molecular biologist. She is therefore in constant contact with the incubator's experts. She now also has a team of students at her side to support her in further development.

Cancer research

In addition to combating the dreaded hospital germs, the researcher sees another possible application. "One of the patents also focuses on the treatment of cancer cells," says Malanovic. The results of studies to date make her confident that peptides are also capable of destroying the outer shell of malignant tumour cells. "That would be a completely new approach to cancer therapy," says Malanovic.

There is still a long way to go before her research can be turned into marketable active ingredients. Once the preclinical challenges have been overcome, the most difficult phase begins: clinical trials on humans. This will require additional investors. But that is still a long way off. "For now, the motto is: Grind, grind, grind," emphasises Malanovic.

Roman Vilgut

Related news

New assessment report: climate change hits Austria particularly hard

Summer is in the starting blocks. Whether it will bring new temperature records remains to be seen. One thing is certain: Over the last few decades, the number of hot days in very hot years has tripled in Austria, as the recently published second Austrian Assessment Report on Climate Change shows. The publication provides well-founded information on observed and expected climate changes and their consequences and describes possible adaptation strategies. In the overall work of more than 200 scientists, researchers from the University of Graz are also responsible for several chapters of the report.

Does protest make freedom? Sociologist Zorica Sirocic analyses Pride movements

In Vienna last Sunday, the rainbow parade was clouded by the school shooting in Graz. In Hungary, on the other hand, the Pride movement could not celebrate at all. Not only was the parade banned by politicians, but also a protest march against the oppression of queer minorities. University of Graz sociologist Zorica Sirocic investigates how the groups concerned are fighting for their rights in south-east Europe.

Zero Emissions Award for more sustainable medicines

Austria's highest privately endowed funding for climate-relevant basic research enters its second round: Rajesh B. Jethwa (ISTA), Eva Maria Prem (University of Innsbruck), and Katalin Barta Weissert (University of Graz) submitted innovative proposals and are the newest recipients of the Zero Emissions Award from the alpha+ Foundation of the Austrian Science Fund (FWF).

Studying at Graz University: Registration for autumn 2025 now open

Ready for a new chapter in your life? Then start your studies at the University of Graz now. Here you will find information on deadlines, admission procedures and registration, as well as everything else you need to get your studies off to a successful start.